(Q34243408)

31 July 2017

title

Brainpeps: the blood-brain barrier peptide database (English)

1 reference

31 July 2017

0 references

1 reference

Antoon Bronselaer

2

0 references

Bart De Spiegeleer

object named as

Bart De Spiegeleer

12

0 references

author name string

Sylvia Van Dorpe

1

1 reference

31 July 2017

Joachim Nielandt

3

1 reference

31 July 2017

Sofie Stalmans

4

1 reference

31 July 2017

Evelien Wynendaele

5

1 reference

31 July 2017

Kurt Audenaert

6

1 reference

31 July 2017

Christophe Van De Wiele

7

1 reference

31 July 2017

Christian Burvenich

8

1 reference

31 July 2017

Kathelijne Peremans

9

1 reference

31 July 2017

Hung Hsuchou

10

1 reference

31 July 2017

Guy De Tré

11

1 reference

31 July 2017

publication date

29 December 2011

1 reference

Brain Structure and Function

31 July 2017

published in

1 reference

31 July 2017

volume

217

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

687-718

1 reference

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Delivery of peptides to the brain: emphasis on therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Passage of peptides across the blood-brain barrier: pathophysiological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of the utility of brain slice methods to study brain penetration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Design and simulation of a high-resolution stationary SPECT system for small animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

How to measure drug transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Delivery of peptides and proteins through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Animal models for studying transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Pharmaceutical and pharmacological importance of peptide transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Delivery of peptide and protein drugs over the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

NORINE: a database of nonribosomal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Systemic low-molecular weight drug delivery to pre-selected neuronal regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In vitro model for evaluating drug transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Modelling of the blood-brain barrier in drug discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

The entity-relationship model---toward a unified view of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A relational model of data for large shared data banks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Facilitated transfer of glucose from blood into brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Drug transport studies using quantitative microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Separation methods that are capable of revealing blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Analytical considerations for microdialysis sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier transport of a novel micro 1-specific opioid peptide, H-Tyr-D-Arg-Phe-beta-Ala-OH (TAPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier permeability of novel [D-arg2]dermorphin (1-4) analogs: transport property is related to the slow onset of antinociceptive activity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

High throughput artificial membrane permeability assay for blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Passage of vasoactive intestinal peptide across the blood–brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In silico prediction models for blood-brain barrier permeation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Transport of the delta-opioid receptor agonist [D-penicillamine2,5] enkephalin across the blood-brain barrier involves transcytosis1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

On the blood-brain barrier to peptides: specific binding of atrial natriuretic peptide in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Deltorphin transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier permeation: molecular parameters governing passive diffusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Development of a high-throughput brain slice method for studying drug distribution in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Transport systems for opioid peptides in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In vitro models for the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Estimates of Michaelis-Menten constants for the two membranes of the brain endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier efflux transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Comparison of in vitro cell models in predicting in vivo brain entry of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

PhytAMP: a database dedicated to antimicrobial plant peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Comparison of in vitro BBMEC permeability and in vivo CNS uptake by microdialysis sampling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Recent advances in the brain-to-blood efflux transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

The fasting polypeptide FGF21 can enter brain from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Assessment of the blood-brain barrier in CNS drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Vasopressin binds to microvessels from rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Brain uptake, pharmacokinetics, and tissue distribution in the rat of neurotoxic N-butylbenzenesulfonamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Brain efflux index method. Characterization of efflux transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Characterization of immobilized artificial membrane (IAM) and XTerra columns by means of chromatographic models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Development of a computational approach to predict blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Progress in brain penetration evaluation in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Ultrasound-enhanced drug transport and distribution in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Graphical analysis of PET data applied to reversible and irreversible tracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry--background and current status in the drug discovery process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Site-specific opening of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Investigation of the high partition of YM992, a novel antidepressant, in rat brain - in vitro and in vivo evidence for the high binding in brain and the high permeability at the BBB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

PEP-FOLD: an online resource for de novo peptide structure prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In vivo, in vitro and in silico methods for small molecule transfer across the BBB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

In vivo evidence for the efflux transport of pentazocine from the brain across the blood-brain barrier using the brain efflux index method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Molecular neuroimaging in rodents: assessing receptor expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Methods to assess drug permeability across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

The PAMPA technique as a HTS tool for partition coefficients determination in different solvent/water systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Permeability of the blood-brain barrier to neurotrophins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Permeation of growth hormone across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Prediction of blood-brain barrier penetration of poorly soluble drug candidates using surface activity profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Characterization of two blood-brain barrier mimicking cell lines: distribution of lectin-binding sites and perspectives for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A critical evaluation of the brain efflux index method as applied to the nitric oxide synthase inhibitor, aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Assessing brain free fraction in early drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

An overview of in vitro techniques for blood-brain barrier studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Inducible and reversible breaching of the blood brain barrier by RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

The internal reference technique in microdialysis: A practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A method to determine the ability of drugs to diffuse through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Murine in vitro model of the blood-brain barrier for evaluating drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A review of blood-brain barrier transport techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Use of immobilized artificial membrane chromatography for drug transport applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Kalman filtering for reliable estimation of BBB permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Partial volume effect compensation for improved reliability of quantitative blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

New approaches to in vitro models of blood-brain barrier drug transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Assaying protein unbound drugs using microdialysis techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Morphine blood-brain barrier transport is influenced by probenecid co-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

A modified fast (4 day) 96-well plate Caco-2 permeability assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Blood-brain barrier transporters and response to CNS-active drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Computation of log BB values for compounds transported through carrier-mediated mechanisms using in vitro permeability data from brain microvessel endothelial cell (BMEC) monolayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Desirability function combining metabolic stability and functionality of peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

PepX: a structural database of non-redundant protein-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

APD2: the updated antimicrobial peptide database and its application in peptide design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Quantitation of blood-brain barrier permeability by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Kinetics of arginine-vasopressin uptake at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Log(BB), PS products and in silico models of drug brain penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

Species independence in brain tissue binding using brain homogenates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00429-011-0375-0

10.1007/S00429-011-0375-0

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference